The iconic rise of Viagra has long been a benchmark of pharmaceutical success, yet its future within the broader industry now raises questions about long-term gains. Generic versions are undercutting https://letsbookmarkit.com/story21455446/the-blue-diamond-and-drug-companies-a-risky-opportunity